ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Oncopeptides presents clinical abstracts on melflufen at the 2021 American Society of Clinical Oncology
May 20, 2021The clinical data presentations include updates on Oncopeptides' ANCHOR and LIGHTHOUSE studies as well as a pooled analysis of the O-12-M1 and HORIZON studies in patients who have been exposed to or become refractory to prior alkylators. -
FDA Grants Priority Review of Melflufen for Triple-Class Refractory Multiple Myeloma
September 02, 2020Oncopeptides has announced the US Food and Drug Administration (FDA) has granted priority review for Oncopeptides' New Drug Application seeking approval of melflufen (INN melphalan flufenamide), in combination with dexamethasone for ...
Pharma Sources Insight January 2025
